These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
579 related articles for article (PubMed ID: 24882401)
1. Effects of Ashwagandha (roots of Withania somnifera) on neurodegenerative diseases. Kuboyama T; Tohda C; Komatsu K Biol Pharm Bull; 2014; 37(6):892-7. PubMed ID: 24882401 [TBL] [Abstract][Full Text] [Related]
2. Withania somnifera (L.) Dunal - Modern perspectives of an ancient Rasayana from Ayurveda. Mukherjee PK; Banerjee S; Biswas S; Das B; Kar A; Katiyar CK J Ethnopharmacol; 2021 Jan; 264():113157. PubMed ID: 32783987 [TBL] [Abstract][Full Text] [Related]
3. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha. Ven Murthy MR; Ranjekar PK; Ramassamy C; Deshpande M Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):238-46. PubMed ID: 20528765 [TBL] [Abstract][Full Text] [Related]
4. Neurodegenerative diseases and Withania somnifera (L.): An update. Dar NJ; Muzamil Ahmad J Ethnopharmacol; 2020 Jun; 256():112769. PubMed ID: 32240781 [TBL] [Abstract][Full Text] [Related]
5. [Overcoming several neurodegenerative diseases by traditional medicines: the development of therapeutic medicines and unraveling pathophysiological mechanisms]. Tohda C Yakugaku Zasshi; 2008 Aug; 128(8):1159-67. PubMed ID: 18670181 [TBL] [Abstract][Full Text] [Related]
6. In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells. Kumar S; Seal CJ; Howes MJ; Kite GC; Okello EJ Phytother Res; 2010 Oct; 24(10):1567-74. PubMed ID: 20680931 [TBL] [Abstract][Full Text] [Related]
7. A double-blind, randomized, placebo-controlled trial on the effect of Ashwagandha (Withania somnifera dunal.) root extract in improving cardiorespiratory endurance and recovery in healthy athletic adults. Tiwari S; Gupta SK; Pathak AK J Ethnopharmacol; 2021 May; 272():113929. PubMed ID: 33600918 [TBL] [Abstract][Full Text] [Related]
8. Ashwagandha- Withania somnifera (L.) Dunal as a multipotent neuroprotective remedy for genetically induced motor dysfunction and cellular toxicity in human neurodegenerative disease models of Drosophila. Murthy MN; Shyamala BV J Ethnopharmacol; 2024 Jan; 318(Pt A):116897. PubMed ID: 37442493 [TBL] [Abstract][Full Text] [Related]
10. Ashwagandha in brain disorders: A review of recent developments. Zahiruddin S; Basist P; Parveen A; Parveen R; Khan W; Gaurav ; Ahmad S J Ethnopharmacol; 2020 Jul; 257():112876. PubMed ID: 32305638 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions. Choudhary D; Bhattacharyya S; Bose S J Diet Suppl; 2017 Nov; 14(6):599-612. PubMed ID: 28471731 [TBL] [Abstract][Full Text] [Related]
12. Keeping abreast about ashwagandha in breast cancer. Vashi R; Patel BM; Goyal RK J Ethnopharmacol; 2021 Apr; 269():113759. PubMed ID: 33359916 [TBL] [Abstract][Full Text] [Related]
13. Rational use of Ashwagandha in Ayurveda (Traditional Indian Medicine) for health and healing. Joshi VK; Joshi A J Ethnopharmacol; 2021 Aug; 276():114101. PubMed ID: 33831467 [TBL] [Abstract][Full Text] [Related]
14. Withania somnifera Extract Protects Model Neurons from In Vitro Traumatic Injury. Saykally JN; Hatic H; Keeley KL; Jain SC; Ravindranath V; Citron BA Cell Transplant; 2017 Jul; 26(7):1193-1201. PubMed ID: 28933215 [TBL] [Abstract][Full Text] [Related]
15. Safety and clinical effectiveness of Withania Somnifera (Linn.) Dunal root in human ailments. Tandon N; Yadav SS J Ethnopharmacol; 2020 Jun; 255():112768. PubMed ID: 32201301 [TBL] [Abstract][Full Text] [Related]
16. Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects. Paul S; Chakraborty S; Anand U; Dey S; Nandy S; Ghorai M; Saha SC; Patil MT; Kandimalla R; Proćków J; Dey A Biomed Pharmacother; 2021 Nov; 143():112175. PubMed ID: 34649336 [TBL] [Abstract][Full Text] [Related]
17. Neuropharmacological Properties of Withania somnifera - Indian Ginseng: An Overview on Experimental Evidence with Emphasis on Clinical Trials and Patents. Yenisetti SC; Manjunath MJ; Muralidhara C Recent Pat CNS Drug Discov; 2016; 10(2):204-215. PubMed ID: 27316579 [TBL] [Abstract][Full Text] [Related]
18. A systematic review of the clinical use of Withania somnifera (Ashwagandha) to ameliorate cognitive dysfunction. Ng QX; Loke W; Foo NX; Tan WJ; Chan HW; Lim DY; Yeo WS Phytother Res; 2020 Mar; 34(3):583-590. PubMed ID: 31742775 [TBL] [Abstract][Full Text] [Related]
19. Antihyperalgesic effects of ashwagandha (Withania somnifera root extract) in rat models of postoperative and neuropathic pain. Lim DW; Kim JG; Lim EY; Kim YT Inflammopharmacology; 2018 Feb; 26(1):207-215. PubMed ID: 28849547 [TBL] [Abstract][Full Text] [Related]
20. Neuro-protective potential of a vesicular system of a standardized extract of a new chemotype of Withania somnifera Dunal (NMITLI118RT+) against cerebral stroke in rats Ahmad H; Khandelwal K; Samuel SS; Tripathi S; Mitra K; Sangwan RS; Shukla R; Dwivedi AK Drug Deliv; 2016 Sep; 23(7):2630-2641. PubMed ID: 26017242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]